BMJ Submission Guide

The path from upload to first decision moves through a sequence BMJ describes on its publishing model page: a same-day screen, a handling-editor review, external peer review and patient review, and a weekly manuscript meeting. The stages below show what the editors are weighing at each point and where most submissions exit the process.

Day of submission: editorial screen

A senior research editor screens every research paper on the day it is submitted. If the editor feels the paper merits further evaluation, it goes to a handling editor. BMJ says about half of original research articles are rejected at this stage, and roughly two thirds of all submissions are rejected without external peer review. For 2019 submissions, the median time to reject a research paper without review was 3 days.

Within 2-3 weeks: first decision aim

BMJ aims to reach a first decision on all manuscripts within two or three weeks, but often the initial decision is done within a few days of submission. If the paper is not right for The BMJ, authors can choose to have it automatically submitted to an alternative BMJ journal, and a Transfer Editor pilot offers a discussion with editors of other BMJ journals for papers that have been through peer review.

External peer review and patient review

If the paper is potentially suitable, the handling editor sends it for external peer review, and patient review also takes place. For 2019 submissions, the median time to first decision for research papers sent for external review was 58 days. BMJ's open peer review means reviewers sign their reports.

Weekly research manuscript meeting

Papers still in the running after peer and patient review are appraised at the weekly research manuscript meeting, where a statistics editor, the paper's handling editor, and four to seven research editors discuss importance, originality, and scientific quality. Decisions usually include provisional acceptance, a request for revisions, or rejection. BMJ sends a decision letter and the meeting report, usually within a few days.

Final decision

BMJ aims to reach a final decision on publication within eight to 10 weeks of submission. When it makes an offer of publication subject to revision, it usually asks authors to return the article within the subsequent month. Major-revision decisions specify the evidence gaps and broaden-the-audience asks that must close before resubmission.

If you are preparing a BMJ submission, the biggest mistake is treating the job as an upload exercise instead of an editorial-fit decision.

Yes, the submission package matters. But the harder question comes first:

Does the manuscript already look like a BMJ paper before you upload anything?

That usually means:

• the clinical or policy importance is obvious early

• the paper matters beyond one narrow specialty

• the evidence package feels complete

• the manuscript reads like it was prepared for a general-medical audience

• the research package is ready for patient-involvement and data-sharing scrutiny, not just peer review

If those conditions are not true, the editor will usually see the mismatch before peer review helps you.

Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: ScholarOne submission portal. Manuscript constraints: structured abstract of 250-300 words (up to 400 for a CONSORT or PRISMA style abstract); no fixed word count limit for research articles.

The named editorial-culture quirk: BMJ editors look for evidence that could change what a practicing clinician does next week, not eventually; methodology must support that practice-relevant claim. We reviewed The BMJ's submission requirements against current author guidelines (accessed 2026-10-08); evidence basis includes both publicly documented author guidelines and Manusights editorial research notes.

This page is about package readiness, not post-upload status interpretation.

Use it when you are still deciding:

• whether the practical or policy consequence is broad enough already

• whether the manuscript is mature enough for a general-medical screen

• whether the title, abstract, and first display make the importance obvious fast enough

• whether the paper was truly prepared for BMJ rather than routed upward from a specialty target

If you want workflow, timing, and what early stages usually mean after upload, that belongs on the submission-process page.

Source: The BMJ publishing model

Before a credible BMJ submission enters the system, the package should already make four things easy to see:

• what the central practice or policy result is

• why it matters beyond the immediate specialty

• why the evidence is strong enough for a broad medical editorial read

• why the manuscript feels operationally complete right now

At a minimum, that usually means:

• a title and abstract that expose the practical consequence quickly

• a first table or figure that supports the main decision case

• reporting, PPI, ethics, and disclosure materials that already look stable

• a Data Availability Statement that is already honest enough to publish

• a manuscript that reads clearly for generalists, not only specialists

• a cover letter that argues audience fit rather than aspiration

• a Patient and Public Involvement Statement that is specific enough to survive editorial scrutiny

The most common failures here are package-shape failures, not upload failures.

• The paper is still specialty-first. Editors can tell when the broad-medical case is being forced.

• The practical consequence is too soft. Strong methods alone do not create BMJ fit.

• The first read is slow. If the title, abstract, and early display do not make the implication obvious, editorial momentum drops quickly.

• The transparency package is underbuilt. Weak reporting, PPI, data-sharing, or disclosure materials make the paper feel less mature.

• The cover letter argues status instead of fit. That usually signals the manuscript wants the logo more than the readership.

The BMJ is not only a prestige journal. It has a specific editorial identity. It rewards manuscripts that matter to clinicians, health systems, and public-health decision-makers, not just to narrow technical specialists.

That means the journal often rewards:

• clinically consequential findings

• policy or systems relevance

• clear implications for practice

• writing that travels beyond one subspecialty audience

It often punishes:

• narrow papers with limited general-medical importance

• manuscripts that feel incomplete

• submissions relying on brand aspiration more than fit

• papers that were clearly written for another journal first

BMJ's current author-policy surface is unusually clear on what research submissions must carry:

• all submitted research articles need a Data Availability Statement

• research submissions need a Patient and Public Involvement Statement in the methods section

• for clinical trials, data-sharing plans and trial-registration consistency matter

• for accepted BMJ research papers, open peer review means the package can become public in detail

The PPI rule is also more nuanced than many authors think. BMJ says it still considers clinical research papers where there has been no patient and public involvement, but authors must say so in the methods section. That means vague silence is worse than a direct explanation.

That matters because BMJ is not only screening the abstract and headline result. It is screening whether the whole research package looks publishable under a high-transparency model.

Many weak BMJ submissions are format or audience mistakes in disguise.

Source: BMJ author guidelines, BMJ

Before you think about article type, ask:

• does the paper matter outside one specialty?

• is the practical implication obvious?

• is the manuscript complete enough for a fast editorial screen?

If the answer is unclear, the fit problem is bigger than the format label.

BMJ editors are usually making an early decision based on fit, importance, and readability.

A weak cover letter does not always kill the paper, but it often confirms an editor's doubts.

For BMJ, the cover letter should do four things:

1. state the clinical or policy question clearly

1. state the main finding plainly

1. explain why the finding matters to BMJ readers

1. signal that the manuscript is complete and submission-ready

What it should not do:

• recite the abstract line by line

• oversell the paper with prestige language

• assume the journal name alone carries the case

• sound interchangeable with a letter for any other medical journal

The best BMJ editor-facing notes are short, plainspoken, and disciplined.

For The BMJ-targeted manuscripts, three patterns consistently predict desk-screen failure at The BMJ (British Medical Journal). These are the patterns handling editors and reviewers catch at first-pass triage.

Scope-fit ambiguity in the abstract

The BMJ editors move fastest on manuscripts whose contribution is obviously aligned with clinical research with practice-changing implications for working clinicians. The named failure pattern: manuscripts that do not explicitly address practice-changing implications in the abstract lose momentum quickly. Check whether your abstract reads to The BMJ's scope

Methods package incomplete for the journal's reviewer pool

The BMJ reviewers expect specific methodological detail. CONSORT trials with half the items showing "see methods" extend revision rounds. Check whether your methods package is reviewer-complete

Reference-list and clean-citation failure mode

Reference lists that cite retracted papers draw reviewer attention. Check whether your reference list is clean against Crossref + Retraction Watch

Editorial evidence signal for The BMJ (British Medical Journal)

Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Bmj editors look for evidence that could change what a practicing clinician does next week, not eventually; methodology must support that practice-relevant claim. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.